Research Proposal and Award Operations During COVID-19 Pandemic

The Sponsored Programs Office remains operational and continues to process proposals and manage awards. Proposals, awards and outgoing subawards related to COVID-19 are being prioritized.

To ensure COVID-19 related actions get prioritized, please ensure the following:

Proposals: The PI must submit projects using Cayuse, include “COVID-19” in the project title, provide budget/budget justification and certify the proposal in Cayuse. PI’s should also send an email to [email protected] identifying the proposal as addressing COVID-19.
Awards/Award Agreements: SPO will prioritize negotiation of COVID-19 awards if we are on notice that the award is for COVID-19. Health System Contracts will negotiate/process industry sponsored human clinical trials. SPO will review/negotiate all other clinical trials, including award coming from industry sponsors using federal funds. PI’s should also send an email to [email protected] identifying the proposal as addressing COVID-19.
Outgoing subawards: “COVID-19” should be in the title of the project.

Agency specific updated on submission deadlines:

NIH released a notice that for all proposals with March and April deadlines may be submitted any time through May 1
NSF published a list of funding opportunities for which they have extended the deadline
USDA describes their deadline extensions here
DOE guidance on submission deadlines can be found here
The Department of Defense recommends speaking directly to program officers to request an extension, or check FOA amendments for agency-issued extensions